The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preventing adverse events in patients with renal cell carcinoma treated with doublet immunotherapy using fecal microbiota transplantation (FMT): Initial results from perform a phase I study.
 
Ricardo Fernandes
Honoraria - Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Canadian Agency for Drugs and Technologies in Health (CADTH)
 
Seema Nair Parvathy
No Relationships to Disclose
 
D. Scott Ernst
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Sanofi
Research Funding - Pfizer
 
Mansour Haeryfar
No Relationships to Disclose
 
Jeremy Burton
Consulting or Advisory Role - Kimberly-Clark; Urobiome Therapeutics
Research Funding - Kimberly-Clark; Urobiome Therapeutics
Patents, Royalties, Other Intellectual Property - Danone; Kimberly-Clark; Multi-magnetics
 
Michael Silverman
Honoraria - Gilead Sciences; Merck; ViiV Healthcare
Consulting or Advisory Role - Gilead Sciences; Merck; ViiV Healthcare
 
Saman Maleki
No Relationships to Disclose